Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck × dostarlimab × 90 days × Clear all

NCT07408063 2026-02-12

BeeHive

Phase 2 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck

NCT06062420 2026-01-09

A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms